Nutritional Status and Clinical Outcomes in Children with Cancer on Admission to Intensive Care Units

Sheng Feng1, Lei Cheng2, Hua Lu1

  • 1Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.

Nutrition and Cancer
|March 20, 2020
PubMed

Insights

Malnutrition is common in pediatric oncology patients in the pediatric intensive care unit (PICU). Poor nutritional status, assessed by various anthropometric measures, is linked to longer mechanical ventilation and PICU stays.

Area of Science:

  • Pediatric Intensive Care
  • Pediatric Oncology
  • Clinical Nutrition

Background:

  • Malnutrition is a significant issue for children with cancer admitted to the pediatric intensive care unit (PICU).
  • This condition is associated with poorer clinical outcomes, highlighting the need for nutritional assessment.

Purpose of the Study:

  • To analyze the prevalence of malnutrition in pediatric oncology patients within the PICU.
  • To investigate the association between nutritional status and clinical outcomes, including mechanical ventilation duration and PICU length of stay.

Main Methods:

  • Secondary data analysis of nutrition and clinical data from 160 pediatric oncology patients admitted to the PICU.
  • Statistical analysis using Cox's regression and Chi-square tests, adjusted for relevant covariates.

Main Results:

  • Prevalence of malnutrition varied by assessment method, with mid-upper arm circumference-for-age showing the highest rate (34.4%).
  • Weight-for-age, height-for-age, weight-for-height, and upper arm muscle area-for-age were significant predictors of mechanical ventilation duration.
  • Weight-for-age also predicted a longer PICU length of stay.

Conclusions:

  • Malnutrition is highly prevalent in pediatric oncology patients in the PICU and negatively impacts clinical outcomes.
  • Comprehensive nutritional status assessment is crucial for this vulnerable patient population to improve care and outcomes.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
562
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
275
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
590
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
180
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
669
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
677